Viewing Study NCT00366977



Ignite Creation Date: 2024-05-05 @ 5:01 PM
Last Modification Date: 2024-10-26 @ 9:27 AM
Study NCT ID: NCT00366977
Status: COMPLETED
Last Update Posted: 2011-05-02
First Post: 2006-08-18

Brief Title: Efficacy and Cost of State Quitline Policies
Sponsor: Kaiser Permanente
Organization: Kaiser Permanente

Study Overview

Official Title: Efficacy and Cost of State Quitline Policies
Status: COMPLETED
Status Verified Date: 2011-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: State-sponsored anti-tobacco campaigns are motivating large numbers of smokers to seek advice assistance and support to make their cessation efforts more successful Like many states Oregon has sponsored the implementation of a statewide telephone quitline to provide information referrals and cessation support for callers This study will answer key policy questions about how to most effectively support smokers who call the Oregon Quitline for assistance The specific aims are to recruit 4500 callers to participate in a 3 x 2 randomized trial comparing the cost and cost effectiveness of three levels of behavioral intervention We will also test two different policies on the availability of nicotine patch therapy Subjects will be interviewed by telephone at 6 and 12 months to assess smoking status quit attempts and use of health plan anc community cessation services Costs will be assessed separately from the perspectives of the patients health plans the State ie Oregon Quitline and society Cost per quit and cost per year quality-adjusted years of life saved will be calculated from each of these perspectives
Detailed Description: Anti-tobacco media campaigns in many states are motivating large numbers of smokers to seek advice assistance and support to make their cessation efforts more successful Like many other states Oregon has sponsored the implementation of a statewide telephone quitline to provide information referrals and cessation support for callers Two investigators on this proposal Hollis and McAfee have a contract with the State of Oregon to provide the Oregon Quitline OQL services The purpose of the proposed research effort is to collaborate further with State representatives to answer key policy questions about how to most effectively support smokers who call the OQL for assistance

Our overall aim is to recruit 4500 callers to the OQL to participate in a 3 x 2 randomized trial to compare the cost and cost effectiveness of three levels of behavioral intervention We will also test two different policies regarding the availability of nicotine patch therapy Subjects will be interviewed by telephone at 6 and 12 months to assess smoking status quit attempts and use of health plan and community cessation services Costs will be assessed separately from the perspective of the patients health plan the State ie OQL and society The specific aims are described below

1 Compare the efficacy of three policies for supporting OQL callers

Brief counseling with referral to callers health plan cessation services standard service
Moderate counseling referral to health plan and one follow-up call to reinforce use of health plan services
Moderate counseling referral and availability a multi-session telephonic intervention
2 Compare the efficacy of two policies regarding the provision of nicotine replacement

No offer of nicotine replacement current policy
An offer of free nicotine replacement patches
3 Determine the costs and cost per quit of the additional policy interventions relative to usual care ie standard service from the following perspectives

Societal perspective total incremental costs per incremental quit
State perspective incremental cost per quit for OQL services
Health plan perspective based on differences in use of health plan cessation services
Participants perspective based on differences in out-of-pocket expenses
4 Determine the incremental cost per year-of-life saved for the alternative policies relative to usual care

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None